Results 151 to 160 of about 151,502 (357)

Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1 [PDF]

open access: bronze, 1999
Zongtang Sun   +10 more
openalex   +1 more source

Seroprevalence of Hepatitis-B Virus and Evaluation of DNA Extraction Methods from Dried Blood Spot on Filter Paper for Molecular Testing in Kaduna State, Nigeria

open access: yesSokoto Journal of Medical Laboratory Science, 2019
Hepatitis B is a potentially life-threatening disease caused by hepatitis B virus. This study was a cross sectional and included a total of 300 paired blood samples collected in tube and on filter paper from students from three secondary schools located ...
Mohammed Ibrahim Tahir * , Ahmed Babangida Suleiman and Abdurrahman El-Fulaty Ahmad
doaj  

An antigen-driven B-cell response within the salivary glands of patients with Sjögren’s syndrome [PDF]

open access: yes, 2002
Infection with a bacterium or virus induces the production of antibodies, specialised protein molecules that bind to and eliminate the microorganism.
Berek, C., Stott, D.I.
core  

Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies [PDF]

open access: yes, 2009
The use of neutralizing antibodies is one of the most successful methods to interfere with receptor–ligand interactions in vivo. In particular blockade of soluble inflammatory mediators or their corresponding cellular receptors was proven an effective ...
Christen, Urs   +2 more
core  

Changing perspectives on liver transplantation in 1988. [PDF]

open access: yes, 1988
After liver transplantation for cancer, there is a high incidence of disease recurrence within 18 to 36 months for most tumors, although there are a small number of long-term survivors.
Gordon, RD, Starzl, TE
core  

Real‐world efficacy and toxicity of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma according to IMDC risk criteria—A multi‐center retrospective analysis on behalf of the GUARDIANS group

open access: yesInternational Journal of Cancer, EarlyView.
What's New? The combination of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma has demonstrated durable response and tolerability in clinical trials. However, inclusion criteria for clinical studies are restrictive, and patients in the real‐world setting tend to have more comorbidities.
Hendrik Dinkel   +21 more
wiley   +1 more source

Exercise serum promotes DNA damage repair and remodels gene expression in colon cancer cells

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Exercise releases bioactive molecules into the bloodstream that can directly slow cancer cell growth. In colon cancer, this may help limit disease progression. Here, using colon cancer cells, the authors investigated the effects of exercise‐conditioned human serum on DNA repair mechanisms. Notably, acute exercise in humans elicited systemic
Samuel T. Orange   +9 more
wiley   +1 more source

Molecular Epidemiology of Hepatitis B Virus in Turkish Cypriot [PDF]

open access: yesPolish Journal of Microbiology, 2019
UNAL SUMER, MURAT SAYAN
doaj   +1 more source

Home - About - Disclaimer - Privacy